[go: up one dir, main page]

JP2005515244A - 原虫症の予防的処置のためのアルキルホスホコリンの使用 - Google Patents

原虫症の予防的処置のためのアルキルホスホコリンの使用 Download PDF

Info

Publication number
JP2005515244A
JP2005515244A JP2003561613A JP2003561613A JP2005515244A JP 2005515244 A JP2005515244 A JP 2005515244A JP 2003561613 A JP2003561613 A JP 2003561613A JP 2003561613 A JP2003561613 A JP 2003561613A JP 2005515244 A JP2005515244 A JP 2005515244A
Authority
JP
Japan
Prior art keywords
active ingredient
leishmaniasis
miltefosine
dose
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003561613A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005515244A5 (es
Inventor
エンゲル ユルゲン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aeterna Zentaris GmbH
Original Assignee
Zentaris AG
Aeterna Zentaris GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris AG, Aeterna Zentaris GmbH filed Critical Zentaris AG
Publication of JP2005515244A publication Critical patent/JP2005515244A/ja
Publication of JP2005515244A5 publication Critical patent/JP2005515244A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2003561613A 2002-01-25 2003-01-07 原虫症の予防的処置のためのアルキルホスホコリンの使用 Pending JP2005515244A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10203195A DE10203195A1 (de) 2002-01-25 2002-01-25 Verwendung von Alkylphosphocholinen in der Präventivbehandlung von Protozoenerkrankungen
PCT/EP2003/000072 WO2003061669A1 (de) 2002-01-25 2003-01-07 Verwendung von alkylphosphocholinen in der präventivbehandlung von protozoenerkrankungen

Publications (2)

Publication Number Publication Date
JP2005515244A true JP2005515244A (ja) 2005-05-26
JP2005515244A5 JP2005515244A5 (es) 2006-01-05

Family

ID=7713213

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003561613A Pending JP2005515244A (ja) 2002-01-25 2003-01-07 原虫症の予防的処置のためのアルキルホスホコリンの使用

Country Status (16)

Country Link
EP (1) EP1467742A1 (es)
JP (1) JP2005515244A (es)
CN (1) CN1622811A (es)
AR (1) AR038224A1 (es)
AU (1) AU2003236787B2 (es)
BR (1) BR0307021A (es)
CA (1) CA2470185A1 (es)
CO (1) CO5601024A2 (es)
DE (1) DE10203195A1 (es)
IL (2) IL162492A0 (es)
MX (1) MXPA04007193A (es)
NZ (1) NZ548040A (es)
PE (1) PE20030732A1 (es)
TW (1) TWI339582B (es)
WO (1) WO2003061669A1 (es)
ZA (1) ZA200404690B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009519999A (ja) * 2005-12-19 2009-05-21 エテルナ ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング 低減された細胞毒性を有するアルキルリン脂質誘導体並びにそれらの使用

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT501545B1 (de) * 2005-02-23 2007-10-15 Obwaller Andreas Dr Reinigungsmittel für kontaktlinsen
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
CN104473941A (zh) * 2014-12-20 2015-04-01 长沙佰顺生物科技有限公司 一种含有米替福新的药物制剂及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06263643A (ja) * 1991-09-27 1994-09-20 Max Planck Ges Foerderung Wissenschaft Ev 原生動物感染症の治療時の経口又は局所投与用薬剤の製造方法
JP2002501015A (ja) * 1998-01-22 2002-01-15 アスタ メディカ アクチエンゲゼルシャフト リーシュマニア症の治療における経口投与のためのミルテフォシンを含有する固形医薬品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4132345A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Ether-lysolecithine und alkylphosphocholine in liposomen
ATE202701T1 (de) * 1992-03-06 2001-07-15 Lica Pharmaceuticals As Behandlung und prophylaxe von durch parasiten oder bakterien verursachten erkrankungen
DE10020812C2 (de) * 2000-04-20 2003-06-26 Robert Koch Inst Verwendung von Naphthindazol-4,9-chinonen als Antiparasitika
WO2002036588A2 (en) * 2000-11-06 2002-05-10 U.S. Army Medical Research And Materiel Command Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06263643A (ja) * 1991-09-27 1994-09-20 Max Planck Ges Foerderung Wissenschaft Ev 原生動物感染症の治療時の経口又は局所投与用薬剤の製造方法
JP2002501015A (ja) * 1998-01-22 2002-01-15 アスタ メディカ アクチエンゲゼルシャフト リーシュマニア症の治療における経口投与のためのミルテフォシンを含有する固形医薬品

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009519999A (ja) * 2005-12-19 2009-05-21 エテルナ ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング 低減された細胞毒性を有するアルキルリン脂質誘導体並びにそれらの使用

Also Published As

Publication number Publication date
IL162492A (en) 2009-12-24
MXPA04007193A (es) 2004-10-29
NZ548040A (en) 2007-06-29
PE20030732A1 (es) 2003-09-27
EP1467742A1 (de) 2004-10-20
BR0307021A (pt) 2004-11-03
WO2003061669A1 (de) 2003-07-31
TWI339582B (en) 2011-04-01
CO5601024A2 (es) 2006-01-31
AR038224A1 (es) 2005-01-05
DE10203195A1 (de) 2003-08-07
ZA200404690B (en) 2004-09-27
TW200302103A (en) 2003-08-01
CN1622811A (zh) 2005-06-01
IL162492A0 (en) 2005-11-20
CA2470185A1 (en) 2003-07-31
AU2003236787B2 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
EP0306060B1 (en) Pharmaceutical products providing enhanced analgesia
JP2015523409A (ja) 鉄欠乏病状に用いるための鉄を含む固体組成物
CN100413492C (zh) 口服给药治疗利什曼病的含有米替福星的固体药物组合物
KR20150131302A (ko) 구강 건조증의 치료 및 치아 치료를 위한 조성물
US7887817B2 (en) Process for preventing protozoal diseases
DE69721756T2 (de) Paroxetine zur behandlung von depression
JP2005515244A (ja) 原虫症の予防的処置のためのアルキルホスホコリンの使用
HU186719B (en) Process for producing pharmaceutical compositions containing meptazinol and ibuprophene or pharmaceutically acceptable salts thereof
JPH07506105A (ja) パーキンソン病の新規な治療方法
HK1077217A (en) Use of alkylphosphocholines for the preventative treatment of protozoan diseases
RU2190390C2 (ru) Твердая фармацевтическая композиция для орального введения при лечении лейшманиоза и способ ее производства, фармацевтическая комбинация для лечения лейшманиоза у млекопитающих и способ лечения (варианты)
RU2174836C1 (ru) Фармацевтическая композиция, обладающая анальгезирующим действием
JPH10509729A (ja) 骨粗鬆症治療サイクル用キット
JPH02311422A (ja) コリン・アセチル転移酵素活性賦活剤
BG64968B1 (bg) Твърди фармацевтични състави, съдържащи милтефозин за орално приложение при лечението на leishmaniasis
US20040010044A1 (en) Medicaments
US3507960A (en) Anti-anxiety compositions and a method of producing anti - anxiety activity with combinations of amobarbital and trifluoperazine
CZ20003885A3 (cs) Použití paroxetinu a farmaceutická kompozice
JPH07188019A (ja) 鎮咳去痰組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051102

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051102

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090708

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091005

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091013

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091106

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100521

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20100622

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20100903

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20101228

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120202

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120208

RD13 Notification of appointment of power of sub attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7433

Effective date: 20120319

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120319